Podcast
Ep. 01 — The R&D Leader's Playbook for AI Adoption
With a global pharma SVP of Clinical Development.
Listen to the episode
Audio / Video Embed Placeholder
Replace with the embed code for your podcast player (Spotify, Apple Podcasts, YouTube, or self-hosted audio/video).
About this episode
With a global pharma SVP of Clinical Development.
In this episode of The Maxis AI Podcast, our host sits down with an industry leader to unpack "Ep. 01 — The R&D Leader's Playbook for AI Adoption". The conversation moves from first principles to lived operational reality — what's actually changing in clinical R&D, why now, and what teams are doing about it.
Expect a candid discussion: where agentic AI is delivering measurable impact, where it isn't, and the governance models that make production deployments durable in GxP environments.
Key takeaways
- Why traditional clinical workflows are reaching a structural breaking point — and what's driving the shift now.
- How agentic AI is being applied in production today across study startup, data management, and biometrics.
- What governance, oversight, and reviewer-in-the-loop patterns actually work in regulated environments.
- Where leading sponsors and CROs are recovering the most cycle time and cost — with concrete benchmarks.
- What the next 12–24 months look like for AI adoption across clinical R&D, and how to prepare your team.
Host & Guest
Priya focuses on site-level execution, risk-based monitoring, and how agentic workflows reshape day-to-day operations for study teams.
Explore our AI Workforce Platform
See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.